Register Login

UNITED THERAPEUTICS CORP (UTHR)

MAHON PAUL A 🟡 adjusted position in 8.3K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $597.54 ($7.3M) Transaction Date: May 07, 2026 | Filing ID: 000011

Full text
Register to leave comments
  • News bot May 7, 2026, 8:32 p.m.

    🔍 MAHON PAUL A (Executive)

    Company: UNITED THERAPEUTICS Corp (UTHR)

    Report Date: 2026-05-07

    Transaction Summary:

    • Total transactions: 10
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 8,300
    • Total shares sold: 16,600

    Detailed Transactions and Holdings:

    • Acquired 8,300 shares of Common Stock at $146.03 per share (Direct)
      Date: 2026-05-07 | Code: M | equity_swap_involved: false | shares_owned_after: 53,472.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 80 shares of Common Stock at $582.8575 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: false | shares_owned_after: 53,392.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,475 shares of Common Stock at $584.0698 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: false | shares_owned_after: 51,917.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 994 shares of Common Stock at $585.1779 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: false | shares_owned_after: 50,923.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 1,689 shares of Common Stock at $586.1724 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: false | shares_owned_after: 49,234.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 2,970 shares of Common Stock at $587.6086 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: false | shares_owned_after: 46,264.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 820 shares of Common Stock at $588.5084 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: false | shares_owned_after: 45,444.00 | transaction_form_type: 4 | Footnotes: F1, F7
    • Sold 70 shares of Common Stock at $596.19 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: false | shares_owned_after: 45,374.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 202 shares of Common Stock at $597.54 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: false | shares_owned_after: 45,172.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 8,300 shares of Stock Option at $146.03 per share (Derivative)
      Date: 2026-05-07 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 300.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
    • F2: This transaction was executed in multiple trades at prices ranging from $582.42 to $583.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F3: This transaction was executed in multiple trades at prices ranging from $583.72 to $584.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F4: This transaction was executed in multiple trades at prices ranging from $584.83 to $585.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F5: This transaction was executed in multiple trades at prices ranging from $585.86 to $586.695. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F6: This transaction was executed in multiple trades at prices ranging from $587.185 to $588.105. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F7: This transaction was executed in multiple trades at prices ranging from $588.195 to $588.7025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Search

News categories